Drug Device Combination Products Market 2022: Size, Share, Trends, Growth and Forecast 2027

According to the latest report by IMARC Group, titled “Drug Device Combination Products Market: Global Industry Trends, Size, Growth, Opportunity and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on the drug device combination products market share. The global drug device combination products market reached a value of US$ 132.45 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 214.53 Billion by 2027, exhibiting at a CAGR of 8.27% during 2022-2027.

Drug device combination products comprise vaccine vials, surgical trays, and prefilled drug delivery systems like syringes and insulin injector pens. They are therapeutic and diagnostic devices that provide safe and effective treatment, precise drug targeting, local administration, and individualized therapy. They aid in treating patients with critical disorders and conditions, such as cancer, heart disease, multiple sclerosis, and diabetes.

Request Free Sample Report: https://www.imarcgroup.com/drug-device-combination-products-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Market Trends:

The increasing number of individuals with chronic medical conditions represents one of the major factors positively influencing the demand for drug device combination products around the world. It can also be attributed to the rising aging population, which is more prone to severe medical ailments, and significant improvement in the healthcare infrastructure and medical services. In addition, the growing adoption of health insurance policies that provide financial assistance for various medical treatments to minimize healthcare expenses is driving the market. Besides this, key players are introducing drug-eluting stents, infusion pumps, photosensitizers, orthopedic combination products, transdermal patches, and inhalers, which is expected to impel the market growth.

Breakup by Product:

  • Drug Eluting Stents

  • Transdermal Patches

  • Infusion Pumps

  • Drug Eluting Balloon

  • Inhalers

  • Others

Breakup by Application:

  • Cardiovascular

  • Diabetes

  • Cancer Treatment

  • Respiratory Diseases

  • Others

Breakup by End User:

  • Hospitals

  • Ambulatory Surgical Centers

  • Others

Breakup by Region:

  • North America: (United States, Canada)

  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)

  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

  • Latin America: (Brazil, Mexico, Others)

  • Middle East and Africa

Competitive Landscape with Key Player:

  • Abbott Laboratories

  • Baxter International Inc.

  • Bayer AG

  • Becton Dickinson and Company

  • Boston Scientific Corporation

  • GlaxoSmithKline plc

  • Johnson & Johnson

  • Medtronic plc

  • Novartis AG

  • Smith & Nephew plc

  • Stryker Corporation

  • Terumo Corporation

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/drug-device-combination-products-market

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Related Reports:

Latin America Dry Eye Syndrome Market Report: https://www.imarcgroup.com/latin-america-dry-eye-syndrome-market

Protein Detection & Quantification Market Report: https://www.imarcgroup.com/protein-detection-quantification-market

Aerosol Delivery Devices Market Report: https://www.imarcgroup.com/aerosol-delivery-devices-market

Onychomycosis Treatment Market Report: https://www.imarcgroup.com/onychomycosis-treatment-market

Lateral Flow Assay Market Report: https://www.imarcgroup.com/lateral-flow-assay-market

Tissue Banking Market Report: https://www.imarcgroup.com/tissue-banking-market

Formulation Development Outsourcing Market Report: https://www.imarcgroup.com/formulation-development-outsourcing-market

Nanopore Technologies Market Report: https://www.imarcgroup.com/nanopore-technologies-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800